Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination | Zendy

Marie Scully | Zendy; Deepak Singh | Zendy; Robert Lown | Zendy; Anthony Poles | Zendy; Tom Solomon | Zendy; Marcel Levi | Zendy; David Goldblatt | Zendy; Pavel Kotouček | Zendy; William D. Thomas | Zendy; Will Lester | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination

Author(s) -

Marie Scully,

Deepak Singh,

Robert Lown,

Anthony Poles,

Tom Solomon,

Marcel Levi,

David Goldblatt,

Pavel Kotouček,

William D. Thomas,

Will Lester

Publication year - 2021

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2105385

Subject(s) - medicine , vaccination , thrombosis , immunology , adverse effect , thrombophilia , antibody , fibrinogen , pandemic , venous thrombosis , disease , covid-19 , infectious disease (medical specialty)

The mainstay of control of the coronavirus disease 2019 (Covid-19) pandemic is vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Within a year, several vaccines have been developed and millions of doses delivered. Reporting of adverse events is a critical postmarketing activity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research